Belvedere Trading »

Cymabay Therapeutics shares owned by Belvedere Trading

Quarter-by-quarter ownership of Cymabay Therapeutics shares owned by Belvedere Trading from 13F filings

Historical chart of Belvedere Trading investment in Cymabay Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Cymabay Therapeutics held by Belvedere Trading consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cymabay Therapeutics by Belvedere Trading

Quarter filed Position value Share count Share price at filing
2023-09-30 $491k 33k 14.91
2022-12-31 $167k 27k 6.27

More positions owned by Belvedere Trading

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Tesla Motors (TSLA)
Ishares Tr Russell 2000 Etf (IWM)
Meta Platforms Cl A (META)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Amazon Call Option (AMZN)
Spdr Gold Tr Gold Shs (GLD)
Microstrategy Cl A New (MSTR)
Ishares Silver Tr Ishares (SLV)
Kraneshares Tr Global Carb Stra (KRBN)
Global X Fds Global X Uranium Call Option (URA)
Alphabet Cap Stk Cl A (GOOGL)
Carvana Cl A Call Option (CVNA)

View all positions for Belvedere Trading

Top funds holding Cymabay Therapeutics

venBio Select Advisor
RA Capital Management
Vanguard Group
Henderson Group
T. Rowe Price Associates
Perceptive Advisors
Jennison Associates
Franklin Resources
Holocene Advisors
Octagon Capital Advisors
Point72 Asset Management
Fred Alger Management
Cormorant Asset Management
First Turn Management
Deutsche Bank Aktiengesellschaft

View all funds holding Cymabay Therapeutics